<--- Back to Details
First PageDocument Content
Microbiology / Typhoid fever / Paratyphoid fever / Enterobacteria / Rose spots / Vi capsular polysaccharide vaccine / Vaccine / Salmonella / Foodborne illness / Medicine / Biology / Health
Date: 2014-11-04 08:26:04
Microbiology
Typhoid fever
Paratyphoid fever
Enterobacteria
Rose spots
Vi capsular polysaccharide vaccine
Vaccine
Salmonella
Foodborne illness
Medicine
Biology
Health

Typhoid and paratyphoid Introduction Epidemiology Risk for travellers Transmission Signs and symptoms

Add to Reading List

Source URL: www.nathnac.org

Download Document from Source Website

File Size: 443,42 KB

Share Document on Facebook

Similar Documents

CVD 103-HgR TRIAL IN MALI

CVD 103-HgR TRIAL IN MALI

DocID: 14wgX - View Document

(Typhoid Vi Capsular Polysaccharide-Tetanus Toxoid Conjugate Vaccine)  New generation typhoid conjugate vaccine for preventing typhoid disease TEAM BHARAT

(Typhoid Vi Capsular Polysaccharide-Tetanus Toxoid Conjugate Vaccine) New generation typhoid conjugate vaccine for preventing typhoid disease TEAM BHARAT

DocID: 14qvK - View Document

Typhoid Vaccines: Current availability, programmatic issues, costs, and vaccine pipeline

Typhoid Vaccines: Current availability, programmatic issues, costs, and vaccine pipeline

DocID: 14nEG - View Document

The global burden of typhoid fever John A. Crump,1, 2 Stephen P. Luby,3 & Eric D. Mintz3 Objective To use new data to make a revised estimate of the global burden of typhoid fever, an accurate understanding of which is n

The global burden of typhoid fever John A. Crump,1, 2 Stephen P. Luby,3 & Eric D. Mintz3 Objective To use new data to make a revised estimate of the global burden of typhoid fever, an accurate understanding of which is n

DocID: 13Bvg - View Document

Sanofi Pasteur 093 Typhim Vi® 1  March 2014, v0.3

Sanofi Pasteur 093 Typhim Vi® 1 March 2014, v0.3

DocID: 12FzM - View Document